Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-001300

Options or other derivatives

  • Chief Executive Officer acquired 3,077,328 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Noble James Chief Executive Officer 2019-01-04 Grant or award · Option to purchase Ordinary Shares +2,515,536 2,515,536 D
Noble James Chief Executive Officer 2019-01-04 Grant or award · Option to purchase Ordinary Shares +561,792 561,792 D
Loading xslF345X03/a4.xml…